帕博利珠单抗联合二甲双胍治疗转移性头颈部癌的 II 期可行性研究
A Phase II Feasibility Study Combining Pembrolizumab and Metformin in Patients with Metastatic Head and Neck Cancer.
二甲双胍联合帕博利珠单抗耐受性良好,仅出现轻度胃肠道不良事件,并展现出有前景的活性,值得在随机试验中进一步研究。
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Tissue-resident memory T cells correlate with the inflammatory tumor microenvironment and improved prognosis in head and neck squamous cell carcinoma.
Tissue-resident memory T cells correlate with the inflammatory tumor microenvironment and improved prognosis in head and neck squamous cell carcinoma.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
我们强调了 T RM 在 HNSCC 患者中的临床和转录组学意义。对 T RM 的进一步表征可能有助于开发新的生物标志物,特别是用于免疫检查点治疗。
肿瘤浸润性T细胞(TIL)是肿瘤微环境(TME)中参与肿瘤清除的主要细胞类型。在TIL中,组织驻留记忆T细胞(T RM)已被认为是能够持续进行免疫监视以提供长期免疫的亚群。在本研究中,我们全面分析了头颈部鳞状细胞癌(HNSCC)患者的T RM。
我们分析了从癌症基因组图谱(TCGA)数据库获得的RNA测序(RNA-seq)数据。基于CD69和CD4/CD8A的基因表达,我们识别了T RM富集的患者,并评估了其临床和生物学意义。此外,我们分析了从60例HNSCC患者获得的外周血单个核细胞(PBMCs),以评估外周循环中是否存在T RM样细胞。
TCGA分析显示,T RM富集型肿瘤与早期T分期、人乳头瘤病毒阳性状态、口咽病变比例、炎症通路上调、免疫刺激和免疫检查点分子基因上调以及有利的总生存期相关。此外,我们阐明了HNSCC患者外周循环中存在高表达PD-1和TIM-3的CD69 + T RM样细胞。
Tumor-infiltrating T cell (TIL) is a major cell type involved in tumor eradication in the tumor microenvironment (TME). Among TILs, tissue-resident memory T cells (T RM s) have been recognized as a subset capable of continuous immunosurveillance to afford long-term immunity. In the present study, we comprehensively profiled T RM in patients with head and neck squamous cell carcinoma (HNSCC).
We analyzed RNA-sequencing (RNA-seq) data obtained from The Cancer Genome Atlas (TCGA) database. Based on the gene expression of CD69 and CD4/CD8A, we identified T RM -enriched patients and evaluated their clinical and biological significance. In addition, we analyzed peripheral blood mononuclear cells (PBMCs) obtained from 60 patients with HNSCC to evaluate the presence of T RM -like cells in the peripheral circulation.
TCGA analysis revealed that T RM -enriched tumors correlated with early T factor, human papillomavirus-positive status, the proportion of oropharynx lesion, upregulated inflammatory pathways, upregulation of immunostimulatory and immune checkpoint molecule genes, and favorable overall survival. Moreover, we clarified the presence of CD69 + T RM -like cells that highly express PD-1 and TIM-3 in the peripheral circulation of patients with HNSCC.
We highlighted the clinical and transcriptomic significance of T RM in patients with HNSCC. Further characterization of T RM could lead to the development of novel biomarkers, especially for immune checkpoint therapies.
MEMBER ACCOUNT
登录成功会直接打开下一页。